Jami F Young1, Jason D Jones2, Robert Gallop3, Jessica S Benas4, Christie M Schueler5, Judy Garber6, Benjamin L Hankin7. 1. Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia. Electronic address: youngjf@email.chop.edu. 2. Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia. 3. West Chester University, West Chester, Pennsylvania. 4. Rutgers University, New Brunswick, New Jersey. 5. Didi Hirsch Mental Health Services, Inglewood, California. 6. Vanderbilt University, Nashville, Tennessee. 7. University of Illinois Urbana-Champaign, Illinois.
Abstract
OBJECTIVE: To evaluate whether evidence-based depression prevention programs can be optimized by matching youths to interventions that address their psychosocial vulnerabilities. METHOD: This randomized controlled trial included 204 adolescents (mean [SD] age = 14.26 [1.65] years; 56.4% female). Youths were categorized as high or low on cognitive and interpersonal risks for depression and randomly assigned to Coping With Stress (CWS), a cognitive-behavioral program, or Interpersonal Psychotherapy-Adolescent Skills Training (IPT-AST), an interpersonal program. Some participants received a match between risk and prevention (eg, high cognitive-low interpersonal risk teen in CWS, low cognitive-high interpersonal risk teen in IPT-AST), others received a mismatch (eg, low cognitive-high interpersonal risk teen in CWS). Outcomes were depression diagnoses and symptoms through 18 months postintervention (21 months total). RESULTS: Matched adolescents showed significantly greater decreases in depressive symptoms than mismatched adolescents from postintervention through 18-month follow-up and across the entire 21-month study period (effect size [d] = 0.44, 95% CI = 0.02, 0.86). There was no significant difference in rates of depressive disorders among matched adolescents compared with mismatched adolescents (12.0% versus 18.3%, t193 = .78, p = .44). CONCLUSION: This study illustrates one approach to personalizing depression prevention as a form of precision mental health. Findings suggest that risk-informed personalization may enhance effects beyond a one-size-fits-all approach. CLINICAL TRIAL REGISTRATION INFORMATION: Bending Adolescent Depression Trajectories Through Personalized Prevention; https://www.clinicaltrials.gov/; NCT01948167.
OBJECTIVE: To evaluate whether evidence-based depression prevention programs can be optimized by matching youths to interventions that address their psychosocial vulnerabilities. METHOD: This randomized controlled trial included 204 adolescents (mean [SD] age = 14.26 [1.65] years; 56.4% female). Youths were categorized as high or low on cognitive and interpersonal risks for depression and randomly assigned to Coping With Stress (CWS), a cognitive-behavioral program, or Interpersonal Psychotherapy-Adolescent Skills Training (IPT-AST), an interpersonal program. Some participants received a match between risk and prevention (eg, high cognitive-low interpersonal risk teen in CWS, low cognitive-high interpersonal risk teen in IPT-AST), others received a mismatch (eg, low cognitive-high interpersonal risk teen in CWS). Outcomes were depression diagnoses and symptoms through 18 months postintervention (21 months total). RESULTS: Matched adolescents showed significantly greater decreases in depressive symptoms than mismatched adolescents from postintervention through 18-month follow-up and across the entire 21-month study period (effect size [d] = 0.44, 95% CI = 0.02, 0.86). There was no significant difference in rates of depressive disorders among matched adolescents compared with mismatched adolescents (12.0% versus 18.3%, t193 = .78, p = .44). CONCLUSION: This study illustrates one approach to personalizing depression prevention as a form of precision mental health. Findings suggest that risk-informed personalization may enhance effects beyond a one-size-fits-all approach. CLINICAL TRIAL REGISTRATION INFORMATION: Bending Adolescent Depression Trajectories Through Personalized Prevention; https://www.clinicaltrials.gov/; NCT01948167.
Authors: J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan Journal: J Am Acad Child Adolesc Psychiatry Date: 1997-07 Impact factor: 8.829
Authors: Judy Garber; Gregory N Clarke; V Robin Weersing; William R Beardslee; David A Brent; Tracy R G Gladstone; Lynn L DeBar; Frances L Lynch; Eugene D'Angelo; Steven D Hollon; Wael Shamseddeen; Satish Iyengar Journal: JAMA Date: 2009-06-03 Impact factor: 56.272
Authors: G N Clarke; W Hawkins; M Murphy; L B Sheeber; P M Lewinsohn; J R Seeley Journal: J Am Acad Child Adolesc Psychiatry Date: 1995-03 Impact factor: 8.829
Authors: Michael W Otto; Jeffrey L Birk; Hayley E Fitzgerald; Gregory V Chauvin; Alexandra K Gold; Jenna R Carl Journal: Clin Psychol Rev Date: 2022-05-23